Related Experiment Video
Updated: Jul 23, 2026
09:58
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
Asthma: the irreversible airways disease
P M Carter1, T L Heinly, S W Yates
1Department of Internal Medicine, University of Tennessee, Memphis, USA.
Journal of Investigational Allergology & Clinical Immunology
|March 10, 1998
Summary
Early inhaled corticosteroid treatment for asthma can prevent irreversible airway remodeling and slow lung function decline. This anti-inflammatory approach is more effective than late treatment for managing chronic asthma inflammation.
Area of Science:
- Pulmonology
- Immunology
- Pathology
Background:
- Chronic asthma inflammation causes airway remodeling, including epithelial changes, smooth muscle hypertrophy, and collagen deposition.
- These structural alterations contribute to increased airway resistance and a progressive decline in forced expiratory volume in one second (FEV1).
Purpose of the Study:
- To investigate the impact of early versus late treatment with inhaled corticosteroids on asthma-related airway remodeling and lung function decline.
- To evaluate the efficacy of anti-inflammatory medications in mitigating the progressive structural changes in asthmatic airways.
Main Methods:
- Review of studies examining the effects of inhaled corticosteroids and bronchodilators on asthmatic airway pathology.
- Analysis of clinical outcomes related to the timing of inhaled corticosteroid initiation and its effect on FEV1 decline.
Main Results:
- Inhaled corticosteroids demonstrably decrease the rate of FEV1 decline in asthma patients.
- Early initiation of inhaled corticosteroid therapy yields superior clinical responses compared to delayed treatment.
- Early intervention with inhaled corticosteroids shows potential in preventing airway remodeling and irreversible structural damage.
Conclusions:
- Early treatment with inhaled corticosteroids is crucial for managing chronic asthma inflammation and preventing progressive lung function loss.
- Anti-inflammatory strategies, particularly early inhaled corticosteroid use, are key to preserving lung architecture and function in asthma.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:24Asthma-III: Symptoms and Complications
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...